A CSIRO study has found MOFs (metal organic frameworks) to be a possible solution to address the challenge of transporting temperature-dependent vaccines. According to the study, for vaccines to work with the maximum potency, they must be stored in specific conditions to avoid degradation across manufacturing, distribution, storage as well as administration; also known as the…
‘Metal-Organic Frameworks’ a Solution to Non-Refrigerated Vaccines: CSIRO
Bayer in Gene Therapy Collaboration With Mammoth Biosciences
FRANKFURT—Bayer on Monday struck a partnership deal with Mammoth Biosciences to develop therapeutic tools based on CRISPR/CAS9 gene editing as the German drug maker seeks to widen its cell and gene therapy development efforts. Unlisted U.S. biotech firm Mammoth will initially receive $40 million from Bayer plus potential milestone payments of more than $1 billion…
US News
RSS Error: A feed could not be found at `https://www.theepochtimes.com/c-us/feed`; the status code is `200` and content-type is `text/html; charset=utf-8`